EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Sleep-related breathing disorders. 5. Nasal continuous positive airway pressure treatment for obstructive sleep apnoea



Sleep-related breathing disorders. 5. Nasal continuous positive airway pressure treatment for obstructive sleep apnoea



Thorax 50(10): 1106-1113



CPAP should be considered the first line of treatment in patients with moderate to severe obstructive sleep apnoea. In our centre in Sydney this generally means patients with more than 20 apnoea/hypopnoeas per hour with repeated dips in oxyhaemoglobin saturation and usually some symptomatology. Despite this first line role of nasal CPAP, recent objective studies question whether earlier enthusiastic reports on adherence to CPAP are correct. The role of technical innovations in new CPAP machines in improving usage remains to be tested. The "drop out" rate from physician selection for a CPAP trial to highly compliant user is certainly more than 50% of patients. What happens to these patients? Data from some studies suggest that surgical treatments are used, at least in the USA, but in all probability many of these patients remain untreated. The challenge in the next decade is either to improve CPAP devices to increase usage in this group or to develop other treatment options. The role of intensive inhospital "acclimatisation" to CPAP also has yet to be objectively tested. It is unclear whether "intelligent" CPAP will make huge inroads in increasing the number of patients who accept CPAP trials, prescriptions, or compliance. It will have minimal impact on patients with mask problems or claustrophobia or those who feel that CPAP is inconvenient. There is a high likelihood that it will reduce technologist workload during CPAP titration studies. "Intelligent" CPAP may help to reduce total overnight mouth leakage and therefore reduce nasal side effects. The current expense of developing such devices will mean that they are unlikely to supersede much cheaper standard "one pressure" CPAP machines in the next few years.

(PDF emailed within 0-6 h: $19.90)

Accession: 033411386

Download citation: RISBibTeXText

PMID: 7491563

DOI: 10.1136/thx.50.10.1106



Related references

Oral appliance therapy versus nasal continuous positive airway pressure in obstructive sleep apnoea syndrome: a randomised, placebo-controlled trial on self-reported symptoms of common sleep disorders and sleep-related problems. Journal of Oral Rehabilitation 44(6): 452-460, 2017

Urinary excretion of guanosine 3':5'-cyclic monophosphate during sleep in obstructive sleep apnoea patients with and without nasal continuous positive airway pressure treatment. Clinical Science 76(1): 31-37, 1989

Nasal continuous positive airway pressure treatment of obstructive sleep apnoea. DMW (Deutsche Medizinische Wochenschrift) 120(22): 783-789, 1995

Treatment of obstructive sleep apnoea with nasal continuous positive airway pressure in stroke. European Respiratory Journal 18(4): 623-629, 2001

Nasal continuous positive airway pressure (nCPAP) therapy in obstructive sleep breathing disorders. Deutsche Medizinische Wochenschrift 120(22): 783-789, 1995

Required levels of nasal continuous positive airway pressure during treatment of obstructive sleep apnoea. European Respiratory Journal 7(10): 1776-1781, 1994

Prevalence and treatment of central sleep apnoea emerging after initiation of continuous positive airway pressure in patients with obstructive sleep apnoea without evidence of heart failure. Sleep & Breathing 16(1): 71-78, 2012

Cerebrospinal fluid leak associated with nasal continuous positive airway pressure treatment for obstructive sleep apnoea. Bmj Case Reports 2010: -, 2013

Impact of nasal continuous positive airway pressure treatment on quality of life in patients with obstructive sleep apnoea. European Respiratory Journal 11(4): 890-894, 1998

Falls in blood pressure in patients with obstructive sleep apnoea after long-term nasal continuous positive airway pressure treatment. Journal of Hypertension 24(10): 2091-2099, 2006

Endothelial injury markers before and after nasal continuous positive airway pressure treatment for obstructive sleep apnoea hypopnoea syndrome. Sleep & Breathing 18(3): 599-607, 2015

Left ventricular function in patients with obstructive sleep apnoea syndrome before and after treatment with nasal continuous positive airway pressure. Respiration; International Review of Thoracic Diseases 67(4): 367-371, 2000

The use of nasal continuous positive airway pressure to treat obstructive sleep apnoea. Archives of Disease in Childhood 87(5): 438-443, 2002

Is (re)titration of nasal continuous positive airway pressure for obstructive sleep apnoea necessary?. Sleep Medicine 2(5): 431-435, 2003

Humidified nasal continuous positive airway pressure in obstructive sleep apnoea. European Respiratory Journal 22(2): 258-262, 2003